Company / R&D Expense
TACTILE SYSTEMS TECHNOLOGY INC R&D Expense History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D Expense
$8.5M
FY2025
5-year range
$5.7M / $8.8M
FY2021-FY2025
Trend
-4.0%
vs FY2024
Sector context
#102 of 105
Health Care
What the data says
Among 105 Health Care companies, TACTILE SYSTEMS TECHNOLOGY INC is in the bottom 3% for r&d expense. R&D Expense has fluctuated over the past 10 years, ranging from $4M in FY2016 to $9M in FY2024.
Based on SEC 10-K filings.
$8M in FY2025 with a 5-year CAGR of +10.0%.
Improved from $8M to $8M over the past 2 years.
Health Care sector context is included.
R&D Expense over time
Growth rates
- 3-Year CAGR
- +6.2%
- 5-Year CAGR
- +10.0%
- 10-Year CAGR
- -
Sector benchmark
Bottom 3% in Health CareTop 97% of 105This company $8.5M Sector average $284.2M
▼
-97.0% below sector average
Key checks
Key Insights
- 5-year CAGR of +10.0%, indicating consistent growth.
- In FY2025, r&d expense decreased 4.0% year-over-year.
- Ranks #102 out of 105 companies in the Health Care sector.
- Peak r&d expense was recorded in FY2024.
Company context
Key Data Points
- Altman Z-Score 3.70 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $8.5M | -4.0% |
| FY2024 | $8.8M | +12.9% |
| FY2023 | $7.8M | +10.4% |
| FY2022 | $7.1M | +25.3% |
| FY2021 | $5.7M | +7.5% |
| FY2020 | $5.3M | +1.7% |
| FY2019 | $5.2M | -2.2% |
| FY2018 | $5.3M | +4.5% |
| FY2017 | $5.1M | +13.0% |
| FY2016 | $4.5M | +3.8% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026